Share
In the healthcare sector, the industry’s core mission revolves around enhancing and preserving lives, which can lead organizations to encounter a multifaceted array of Environmental, Social, and Governance (ESG) challenges. While these challenges are diverse and extend beyond the scope of this introduction, it's essential to identify, comprehend, and effectively manage them within a strategic ESG due diligence framework.
By taking a proactive approach to addressing ESG risks, organizations can ensure the delivery of equitable care, safeguarding of patient data, adherence to ethical business practices, and promotion of inclusivity in clinical trials. This comprehensive strategy not only ensures compliance but may also generate substantial value in a critical sector.
Identifying ESG Risks
Within the healthcare industry, numerous pivotal ESG risks have been discerned; each serving as a fundamental catalyst in molding the future industry landscape. These risks form the core of our ESG due diligence framework and facilitate a comprehensive evaluation specific to an individual asset. Below, we delve into a select few key ESG risks within the domain:
Access to Care
Organizations delivering care or manufacturing medicines are under pressure to offer equitable access to care. They face reputational risks if they ignore the impact on groups of patients who are unequally afforded access to care. Ensuring access to quality healthcare for all is not only an ethical imperative but also a strategic necessity.
Patient Data Security
Patient data security is a direct risk for organizations that handle or protect patient data, including those involved in developing precision medicine. Safeguarding patient information is paramount not only to comply with regulations but also to maintain trust and confidence in healthcare services.
Business Ethics
Fee-for-service reimbursement models may incentivize health organizations to deliver more care than is medically necessary. This exposes them to regulatory and public scrutiny if ethical business practices are abused. Upholding the highest ethical standards in healthcare delivery is vital for maintaining public trust.
Diversity & Inclusion in Clinical Trials
Companies developing medicines face growing public pressure to include a diverse and representative patient mix in clinical research trials. Ensuring diversity in clinical trials not only enhances the validity of research but also contributes to addressing healthcare disparities among different demographic groups.
ESG Due Diligence Process
Stax’s ESG due diligence process involves a thorough assessment of material ESG risks across industries. We go beyond identification and provide strategic recommendations on how to track, monitor, and minimize risks during the ownership period. By implementing recommendations, organizations can ensure they are on the right path to meeting asset-specific ESG goals and responsibilities.
By proactively addressing ESG risks, organizations in the healthcare sector can enhance their reputations, strengthen patient trust, and contribute to the overall well-being of society. As the healthcare landscape evolves, it will become increasingly essential for organizations to embed ESG strategies into their operations, ensuring both patients and the healthcare ecosystem as a whole benefit.
Read More
Grant Thornton Stax Appoints Chen Liu as Partner to Drive Growth in Technology and Education Sectors
